Valganciclovir is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of CMV retinitis (AIDS).
- Prevention of CMV disease: renal, cardiac and kidney-pancreas transplant patients at high risk for CMV disease (e.g., donor positive, recipient negative).
- Not indicated in liver transplant patients.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Prevention of disseminated CMV disease of the contralateral eye in patients treated with intraocular ganciclovir implant (no longer manufactured).
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: January 6, 2016
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Valganciclovir
ID - 540577
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Hsu,Alice,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2016/01/06/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540577/all/Valganciclovir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -